SOURCE: BioCentric Energy Holdings, Inc.

BioCentric Energy Holdings, Inc.

August 04, 2009 11:22 ET

BioCentric Energy Important Announcement

SAN JUAN CAPISTRANO, CA--(Marketwire - August 4, 2009) - BioCentric Energy Holdings, Inc. (PINKSHEETS: BEHL) today announced the Press Release dated August 4th, 2009 issued by Skymark Research was not authorized by the Company and has no agreement with Skymark Research of any kind. The company has formerly notified Skymark Research to retract the Press Release. If the Press Release is not fully retracted the company will immediately take all steps necessary to prevent the erroneous use of BioCentric stock symbol for promotion of unauthorized companies.

Relevant Links & Articles

About BioCentric Energy Holdings, Inc.

BioCentric Energy Holdings, Inc. is dedicated to the development of new technologies as well as acquiring and fostering companies with innovative technologies designed to provide unique and effective green energy solutions for the 21st century. Along with the cultivation of important relationships and partnerships with synergistic entities, BioCentric Energy has devoted substantial time and effort in research and development in order to bring a range of innovative green alternatives to the marketplace.

Safe Harbor Statement: This release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as BEHL or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

VOD Newswire Video Format:

Contact Information

  • Dale Baeten
    BioCentric Investor Relations:
    Office: 920-273-7941